0
Skip to Content
Gadolinium 64
Letters
Letter to RFK Jr.
2020 Letter to FDA
2012 Letter to FDA
About Gd
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Advocacy
History of Harm
Timeline
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
GBCA Forms
Media
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Patients
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Physicians
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Support Us
Goals
Donate
Contact Us
Sign the Petition
Make FDA Report
Gadolinium 64
Letters
Letter to RFK Jr.
2020 Letter to FDA
2012 Letter to FDA
About Gd
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Advocacy
History of Harm
Timeline
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
GBCA Forms
Media
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Patients
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Physicians
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Support Us
Goals
Donate
Contact Us
Sign the Petition
Make FDA Report
Folder: Letters
Back
Letter to RFK Jr.
2020 Letter to FDA
2012 Letter to FDA
Folder: About Gd
Back
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Advocacy
Folder: History of Harm
Back
Timeline
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
GBCA Forms
Folder: Media
Back
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Folder: Patients
Back
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Folder: Physicians
Back
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Folder: Support Us
Back
Goals
Donate
Contact Us
Sign the Petition
Make FDA Report

Categories: All Articles • Nanoparticles • Dechelation • Cellular + Mito Dysfunction • GDD/Toxicity • Fibrosis • Other Disease • Chemistry • Heavy Metal Toxicity • Treatment Options • Water Contamination • Other Gd Uses • Pediatrics • Chelators

(Pre-publication) The Brass Tacks of Gadolinium Toxicity: Precipitation of Gadolinium Oxalate from Magnetic Resonance Imaging Contrast Agents (still needs peer-reviewed verification) (Nov 2024).
Nanoparticles, Cellular, Chelator, Dechelation, Chemistry Bridget Belo 12/28/24 Nanoparticles, Cellular, Chelator, Dechelation, Chemistry Bridget Belo 12/28/24

(Pre-publication) The Brass Tacks of Gadolinium Toxicity: Precipitation of Gadolinium Oxalate from Magnetic Resonance Imaging Contrast Agents (still needs peer-reviewed verification) (Nov 2024).

Read More
Ultra-inert lanthanide chelates as mass tags for multiplexed bioanalysis (Nov 2024).
Chelator, Dechelation, Chemistry Bridget Belo 11/13/24 Chelator, Dechelation, Chemistry Bridget Belo 11/13/24

Ultra-inert lanthanide chelates as mass tags for multiplexed bioanalysis (Nov 2024).

Read More
Advancements in nano drug delivery system for liver cancer therapy based on mitochondria-targeting (Oct 2024).
Nanoparticles, Other Gd Uses, Other Disease Bridget Belo 11/1/24 Nanoparticles, Other Gd Uses, Other Disease Bridget Belo 11/1/24

Advancements in nano drug delivery system for liver cancer therapy based on mitochondria-targeting (Oct 2024).

Read More
Metal in MRI contrast agents may cause serious health problems (Oct 2024).
Heavy Metal Toxicity Bridget Belo 10/10/24 Heavy Metal Toxicity Bridget Belo 10/10/24

Metal in MRI contrast agents may cause serious health problems (Oct 2024).

Read More
The Safety of Magnetic Resonance Imaging Contrast Agents (Aug 2024).
Chelator, GDD/Toxicity, Fibrosis Bridget Belo 8/11/24 Chelator, GDD/Toxicity, Fibrosis Bridget Belo 8/11/24

The Safety of Magnetic Resonance Imaging Contrast Agents (Aug 2024).

Read More
Deposition of Gadolinium in the Central and Peripheral Nervous Systems and Its Effects on Sensory, Cognitive, and Athletic Implications after Injections of GBCAs in Rats (2024).
GDD/Toxicity Kate 7/1/24 GDD/Toxicity Kate 7/1/24

Deposition of Gadolinium in the Central and Peripheral Nervous Systems and Its Effects on Sensory, Cognitive, and Athletic Implications after Injections of GBCAs in Rats (2024).

Read More
Anthropogenic gadolinium in the Tone River (Japan): an update showing a 7.7-fold increase from 1996 to 2020 (2024).
Water Contamination Kate 5/24/24 Water Contamination Kate 5/24/24

Anthropogenic gadolinium in the Tone River (Japan): an update showing a 7.7-fold increase from 1996 to 2020 (2024).

Read More
Toxicity Mechanisms of Gadolinium and Gadolinium-Based Contrast Agents—A Review (2024).
GDD/Toxicity, All, Chelator, Cellular/Mitochondria dysfunction, Fibrosis Bridget Belo 4/1/24 GDD/Toxicity, All, Chelator, Cellular/Mitochondria dysfunction, Fibrosis Bridget Belo 4/1/24

Toxicity Mechanisms of Gadolinium and Gadolinium-Based Contrast Agents—A Review (2024).

Read More
Unveiling the next generation of MRI contrast agents: current insights and perspectives on ferumoxytol-enhanced MRI (2024).
Treatment Options Kate 2/7/24 Treatment Options Kate 2/7/24

Unveiling the next generation of MRI contrast agents: current insights and perspectives on ferumoxytol-enhanced MRI (2024).

Read More
Gadolinium Effects on Liposome Fluidity and Size Depend on the Headgroup and Side Chain Structure of Key Mammalian Brain Lipids (Dec 2023).
Cellular/Mitochondria dysfunction, Other Gd Uses, Chemistry, Water Contamination, GDD/Toxicity, Other Disease, Heavy Metal Toxicity Bridget Belo 12/25/23 Cellular/Mitochondria dysfunction, Other Gd Uses, Chemistry, Water Contamination, GDD/Toxicity, Other Disease, Heavy Metal Toxicity Bridget Belo 12/25/23

Gadolinium Effects on Liposome Fluidity and Size Depend on the Headgroup and Side Chain Structure of Key Mammalian Brain Lipids (Dec 2023).

Read More
Uptake of Gadolinium-Based Contrast Agents by Blood Cells During Contrast-Enhanced MRI Examination
GDD/Toxicity, Cellular/Mitochondria dysfunction, Fibrosis Bridget Belo 8/15/23 GDD/Toxicity, Cellular/Mitochondria dysfunction, Fibrosis Bridget Belo 8/15/23

Uptake of Gadolinium-Based Contrast Agents by Blood Cells During Contrast-Enhanced MRI Examination

Read More
Gadolinium Deposition Disease Current State of Knowledge and Expert Opinion (2023).
GDD/Toxicity, Chelators Kate 8/1/23 GDD/Toxicity, Chelators Kate 8/1/23

Gadolinium Deposition Disease Current State of Knowledge and Expert Opinion (2023).

Read More
Gadolinium contrast agents- challenges and opportunities of a multidisciplinary approach: Literature review (July 2023).
GDD/Toxicity, Chemistry, Heavy Metal Toxicity Bridget Belo 7/4/23 GDD/Toxicity, Chemistry, Heavy Metal Toxicity Bridget Belo 7/4/23

Gadolinium contrast agents- challenges and opportunities of a multidisciplinary approach: Literature review (July 2023).

Read More
Metalloglycobiology: The power of metals in regulating glycosylation (June 2023).
Cellular/Mitochondria dysfunction, General Chemistry Bridget Belo 6/20/23 Cellular/Mitochondria dysfunction, General Chemistry Bridget Belo 6/20/23

Metalloglycobiology: The power of metals in regulating glycosylation (June 2023).

Read More
Relationship between gadolinium-based MRI contrast agent consumption and anthropogenic gadolinium in the influent of a wastewater treatment plant (June 2023).
Water Contamination Bridget Belo 6/15/23 Water Contamination Bridget Belo 6/15/23

Relationship between gadolinium-based MRI contrast agent consumption and anthropogenic gadolinium in the influent of a wastewater treatment plant (June 2023).

Read More
The onset of rare earth metallosis begins with renal gadolinium-rich nanoparticles from magnetic resonance imaging contrast agent exposure (2023).
Nanoparticles, GDD/Toxicity, Other Disease Bridget Belo 2/4/23 Nanoparticles, GDD/Toxicity, Other Disease Bridget Belo 2/4/23

The onset of rare earth metallosis begins with renal gadolinium-rich nanoparticles from magnetic resonance imaging contrast agent exposure (2023).

Read More
Altered Functional Mitochondrial Protein Levels in Plasma Neuron-Derived Extracellular Vesicles of Patients With Gadolinium Deposition (2022).
GDD/Toxicity, Chelator, Cellular/Mitochondria dysfunction Bridget Belo 1/11/23 GDD/Toxicity, Chelator, Cellular/Mitochondria dysfunction Bridget Belo 1/11/23

Altered Functional Mitochondrial Protein Levels in Plasma Neuron-Derived Extracellular Vesicles of Patients With Gadolinium Deposition (2022).

Read More
Commentary on the Association of Symptoms Associated With Gadolinium Exposure/Gadolinium Deposition Disease and Gadolinium-Based Contrast Agents (2022).
GDD/Toxicity, Treatment Options, Chelators Kate 10/1/22 GDD/Toxicity, Treatment Options, Chelators Kate 10/1/22

Commentary on the Association of Symptoms Associated With Gadolinium Exposure/Gadolinium Deposition Disease and Gadolinium-Based Contrast Agents (2022).

Read More
Older Posts

Submit any resources that should be included on the site.

Explore Gadolinium 64

Physicians

Donate

This site is also accessible via contrastdie.com
 
Fair Use Disclaimer
This website features copyrighted material used in accordance with the principles of fair use as outlined in Section 107 of the U.S. Copyright Act. The material is provided to inform, educate, and encourage public discussion on important issues, including health, education, and science. All content is shared with the intent of advancing understanding and fostering meaningful dialogue. This use is non-commercial and aligns with fair use standards for purposes such as research, education, and commentary. If you believe any content on this site infringes on your copyright, please contact us at Contact Us and we will review your concerns promptly.